21,719 Shares in Definitive Healthcare Corp. (NASDAQ:DH) Acquired by Heron Bay Capital Management

Heron Bay Capital Management purchased a new position in Definitive Healthcare Corp. (NASDAQ:DH) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 21,719 shares of the company’s stock, valued at approximately $89,000.

A number of other institutional investors and hedge funds have also modified their holdings of DH. KLP Kapitalforvaltning AS acquired a new stake in Definitive Healthcare during the 4th quarter valued at $54,000. Quantbot Technologies LP grew its holdings in Definitive Healthcare by 5,305.5% during the 4th quarter. Quantbot Technologies LP now owns 17,730 shares of the company’s stock valued at $73,000 after buying an additional 17,402 shares during the last quarter. Intech Investment Management LLC grew its holdings in Definitive Healthcare by 166.1% during the 4th quarter. Intech Investment Management LLC now owns 32,979 shares of the company’s stock valued at $136,000 after buying an additional 20,586 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Definitive Healthcare by 28.0% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 146,623 shares of the company’s stock valued at $603,000 after buying an additional 32,071 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its holdings in Definitive Healthcare by 928.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 156,997 shares of the company’s stock valued at $645,000 after buying an additional 141,729 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Trading Up 0.7 %

Shares of DH opened at $2.81 on Friday. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $317.28 million, a P/E ratio of -0.91, a price-to-earnings-growth ratio of 4.06 and a beta of 1.51. The stock’s fifty day simple moving average is $4.19 and its 200 day simple moving average is $4.31. Definitive Healthcare Corp. has a twelve month low of $2.55 and a twelve month high of $8.35.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million during the quarter, compared to analysts’ expectations of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, equities research analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Barclays lowered their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. The Goldman Sachs Group reduced their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, Stephens began coverage on Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and an average target price of $5.35.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.